Cleared Traditional

K962841 - OPUS MYOGLOBIN CONTROLS

K962841 is the FDA 510(k) clearance for OPUS MYOGLOBIN CONTROLS by Behring Diagnostics, Inc.. It is a Class 1 Immunology device (product code JJX) cleared through the Traditional 510(k) pathway after a 24-day FDA review.

K962841 · Behring Diagnostics, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1996
Decision
24d
Days
Class 1
Risk

K962841 is an FDA 510(k) clearance for the OPUS MYOGLOBIN CONTROLS. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Behring Diagnostics, Inc. (Westwood, US). The FDA issued a Cleared decision on August 15, 1996 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Behring Diagnostics, Inc. devices

Submission Details

510(k) Number K962841 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 1996
Decision Date August 15, 1996
Days to Decision 24 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 104d · This submission: 24d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 370
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K962841.
ELECSYS CALCHECK TROPONIN T
K963143 · Boehringer Mannheim Corp. · Aug 1996
ELECSYS CALCHECK TSH
K963147 · Boehringer Mannheim Corp. · Aug 1996
ELECSYS CALCHECK CK-MB
K963182 · Boehringer Mannheim Corp. · Aug 1996
ELECSYS PRECICONTROL TSH
K962573 · Boehringer Mannheim Corp. · Jul 1996
OPUS B12 CONTROLS
K962694 · Behring Diagnostics, Inc. · Jul 1996
ACS FRT4 IMMUNOASSAY
K961510 · Ciba Corning Diagnostics Corp. · Jun 1996